ROIV Competitors & Alternatives
Compare Roivant Sciences Ltd with similar stocks in the same industry
Biotechnology
ROIV
Main Stock$36.80
Tradestie Score
62
Market Cap
$10.76B
Revenue Growth
-0.3%
Analyst Upside
+31.2%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$386.46
|
$36.81B | 68.8 | 47 | Compare |
|
INSM
Insmed, Inc.
|
$94.04
|
$31.13B | - | 60 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$91.29
|
$24.57B | - | 64 | Compare |
|
GMAB
Genmab A/S ADS
|
$39.57
|
$19.56B | 30.8 | 43 | Compare |
|
INCY
Incyte Genomics Inc
|
$113.44
|
$16.93B | 14.9 | 76 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$62.15
|
$15.70B | 33.1 | 44 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.83
|
$15.22B | - | 49 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$238.90
|
$12.36B | 17.6 | 51 | Compare |
|
EXEL
Exelixis Inc
|
$64.58
|
$11.09B | 20.3 | 38 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$245.81
|
$10.74B | - | 35 | Compare |
More ROIV Analysis
Data updated: Oct 21, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry